本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pacira Pharmaceuticals

24.67
+0.84003.52%
盘后24.18-0.4900-1.99%18:29 EDT
成交量:47.54万
成交额:1,161.14万
市值:9.83亿
市盈率:70.13
高:24.72
开:23.91
低:23.66
收:23.83
52周最高:27.66
52周最低:18.80
股本:3,986.19万
流通股本:3,636.93万
量比:0.96
换手率:1.31%
股息:- -
股息率:- -
每股收益(TTM):0.3518
每股收益(LYR):0.1578
净资产收益率:2.05%
总资产收益率:1.48%
市净率:1.46
市盈率(LYR):156.30

数据加载中...

2026/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/04

重要事件披露

Form 8-K - Current report
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/09

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities